Chris Potochar
Vice President of Treasury and Investor Relations
Replay available
Oscar Health, Inc. (NYSE: OSCR) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Vice President of Treasury and Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Barclays
Analyst, Piper Sandler
Analyst, Raymond James
Analyst, Wells Fargo
Analyst, Goldman Sachs
Analyst, Stevens Inc.
Analyst, UBS
Analyst, Bank of America
Analyst, Jefferies
Analyst, Wolfe Research
Analyst, Baird
Good morning. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's second quarter 2026 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Today, we do ask you limit yourself to one question and one follow-up. Thank you. I will now turn the call over to Chris Potochar, Vice President of Treasury and Investor Relations. Good morning, everyone. Thank you for joining us for our second quarter 2026 earnings call. Mark Bertolini, Oscar Hell's Chief Executive Officer, and Scott Blackley, Oscar Hell's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com. All details of our results and additional management commentary are available in our earnings release, which can be found on our investor relations website at ir.hioscar.com. Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the period ended December 31st, 2025 and the quarterly report on Form 10-Q for the period ended March 31st, 2026 each is filed with the Securities and Exchange Commission and other filings with the SEC i...